Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renzo Galanello

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Expert Review of Clinical Pharmacology|January 16, 2014
Once-daily oral deferasirox for the treatment of transfusional iron overloadRenzo Galanello, Raffaella Origa
Pediatric Reports|July 21, 2011
Recent advances in β-thalassemiasAntonio Cao, Paolo Moi, Renzo Galanello
Haematologica|November 8, 2011
Beta-thalassemia: from genotype to phenotypeFabrice Danjou, Franco Anni, Renzo Galanello
Expert Opinion on Drug Metabolism & Toxicology|December 20, 2011
Deferasirox: pharmacokinetics and clinical experienceRenzo Galanello, Simona Campus, Raffaella Origa
EJIFCC|February 2, 2019
Prenatal Diagnosis and Screening of the HaemoglobinopathiesAntonio Cao, Renzo Galanello, M Cristina Rosatelli
Blood Cells, Molecules & Diseases|December 16, 2011
Responsiveness to oral iron and ascorbic acid in a patient with IRIDAMilena Cau, Renzo Galanello, Nicolina Giagu, et al.
Expert Review of Hematology|November 19, 2010
Iron-deficiency anemia secondary to mutations in genes controlling hepcidinMilena Cau, Maria Antonietta Melis, Rita Congiu, et al.
Obstetrics and Gynecology Clinics of North America|July 11, 2002
Screening for thalassemia: a model of successAntonio Cao, Maria Cristina Rosatelli, Giovanni Monni, et al.
British Journal of Haematology|May 27, 2009
Use of erythropoiesis stimulating agents for the treatment of anaemia and related fatigue in a pregnant woman with HbH diseaseAntonio Macciò, Clelia Madeddu, Paola Chessa, et al.
Blood Cells, Molecules & Diseases|November 19, 2011
Delayed fetal hemoglobin switching in subjects with KLF1 gene mutationStefania Satta, Lucia Perseu, Liliana Maccioni, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Expert Review of Clinical Pharmacology|January 16, 2014
Once-daily oral deferasirox for the treatment of transfusional iron overloadRenzo Galanello, Raffaella Origa
Pediatric Reports|July 21, 2011
Recent advances in β-thalassemiasAntonio Cao, Paolo Moi, Renzo Galanello
Haematologica|November 8, 2011
Beta-thalassemia: from genotype to phenotypeFabrice Danjou, Franco Anni, Renzo Galanello
Expert Opinion on Drug Metabolism & Toxicology|December 20, 2011
Deferasirox: pharmacokinetics and clinical experienceRenzo Galanello, Simona Campus, Raffaella Origa
EJIFCC|February 2, 2019
Prenatal Diagnosis and Screening of the HaemoglobinopathiesAntonio Cao, Renzo Galanello, M Cristina Rosatelli
Blood Cells, Molecules & Diseases|December 16, 2011
Responsiveness to oral iron and ascorbic acid in a patient with IRIDAMilena Cau, Renzo Galanello, Nicolina Giagu, et al.
Expert Review of Hematology|November 19, 2010
Iron-deficiency anemia secondary to mutations in genes controlling hepcidinMilena Cau, Maria Antonietta Melis, Rita Congiu, et al.
Obstetrics and Gynecology Clinics of North America|July 11, 2002
Screening for thalassemia: a model of successAntonio Cao, Maria Cristina Rosatelli, Giovanni Monni, et al.
British Journal of Haematology|May 27, 2009
Use of erythropoiesis stimulating agents for the treatment of anaemia and related fatigue in a pregnant woman with HbH diseaseAntonio Macciò, Clelia Madeddu, Paola Chessa, et al.
Blood Cells, Molecules & Diseases|November 19, 2011
Delayed fetal hemoglobin switching in subjects with KLF1 gene mutationStefania Satta, Lucia Perseu, Liliana Maccioni, et al.
Pageof 12